Cryopyrin activates the inflammasome in response to toxins and ATP-Reference-Cited by-同舟云学术

Cryopyrin activates the inflammasome in response to toxins and ATP

Published:2006-01-11 Issue:7081 Volume:440 Page:228-232
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Mariathasan Sanjeev,Weiss David S.,Newton Kim,McBride Jacqueline,O'Rourke Karen,Roose-Girma Meron,Lee Wyne P.,Weinrauch Yvette,Monack Denise M.,Dixit Vishva M.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature04515.pdf

Reference25 articles.

1. Mariathasan, S. et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213–218 (2004)

2. Martinon, F., Burns, K. & Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 10, 417–426 (2002)

3. Srinivasula, S. M. et al. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J. Biol. Chem. 277, 21119–21122 (2002)

4. Wang, L. et al. PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-κB and caspase-1-dependent cytokine processing. J. Biol. Chem. 277, 29874–29880 (2002)

5. Agostini, L. et al. NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20, 319–325 (2004)

Cited by 2577 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammation and gut microbiota in the alcoholic liver disease;Food & Medicine Homology;2024-12

2. Epinephelus coioides NLRP3 inhibits SGIV infection by upregulating Capspase-1 activity;Fish & Shellfish Immunology;2024-10

3. Potential Impact of Bioactive Compounds as NLRP3 Inflammasome Inhibitors: An Update;Current Pharmaceutical Biotechnology;2024-10

4. Friendly fire: recognition of self by the innate immune system;Current Opinion in Immunology;2024-10

5. Bystander monocytic cells drive infection-independent NLRP3 inflammasome response to SARS-CoV-2;mBio;2024-09-06